单中心脊髓保护方案综述:分支型血管腔内主动脉修复中脊髓引流与内科管理的应用对比
单中心回顾性分析2012至2021年174例医师改良分支型血管腔内主动脉修复患者,2019年11月起实施标准化神经保护方案。方案实施后高危患者脊髓缺血事件由17.1%降至0%(P=0.0407),肾功能衰竭与1年死亡率亦改善。
要点
- 标准化神经保护方案实施后,高危患者脊髓缺血事件降至0%(0% vs 17.1%,P=0.0407)。
- 方案实施后脊髓引流使用率降低(6% vs 38.3%,P<0.0001)。
- 方案实施后1年死亡率改善(9% vs 27.1%,P=0.0035)。
核心结论
- 实施以内科管理和液体动力学为核心的标准化神经保护方案,可能显著降低分支型血管腔内主动脉修复后脊髓缺血风险,对脊髓缺血风险最高者改善最明显。
- 方案实施后1年生存率亦有显著改善。
研究设计与样本
- 单中心回顾性综述,2012至2021年连续174例医师改良分支型血管腔内主动脉修复患者,比较方案实施前(n=107)与实施后(n=67)结局。
- 标准化神经保护方案于2019年11月启动,包括术前类固醇、乙酰唑胺、术中血流动力学参数及术后治疗目标。
- 主要终点为30天任何脊髓缺血事件发生率,次要终点包括30天全因死亡、卒中、心肌梗死和肾功能衰竭。
- Crawford I-III型、肾功能衰竭或需急诊修复的患者被视为脊髓缺血高危并做亚组分析,脊髓缺血后生存用Kaplan-Meier表估计。
主要发现
- 方案实施后组较实施前组更常见既往心肌梗死(26.9% vs 14%,P=0.0466)和慢性阻塞性肺疾病史(64.3% vs 45.8%,P=0.02),且更多因内脏旁动脉瘤接受治疗(53.7% vs 24.3%,P=0.0002)。
- 方案实施后脊髓引流使用率降低(6% vs 38.3%,P<0.0001),且这些引流100%作为方案一部分 placed 于急诊或非分期胸腹主动脉瘤修复中。
- 全部患者方案实施前后任何脊髓缺血事件发生率分别为9.3%(107例中10例)和6%(67例中4例,P=0.57)。
- 高危患者中方案显著降低脊髓缺血率至0(0% vs 17.1%,P=0.0407)。
- 方案启动后肾功能衰竭频率降低(3% vs 14%,P=0.018),方案实施后组1年死亡率(9% vs 27.1%,P=0.0035)和肾功能衰竭率(2% vs 15%,P=0.018)显著改善。
临床怎么用
- 作者认为,实施以内科管理和液体动力学为核心的标准化神经保护方案可能显著降低分支型血管腔内主动脉修复后脊髓缺血风险,对风险最高者改善最明显。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Spinal cord ischemia (SCI) continues to be a devastating complication after repair of thoracoabdominal aortic aneurysms. The objective of this review is to present our single-center outcomes after the implementation of a standardized neuroprotective protocol following branched endovascular aortic repair. METHODS: A standardized neuroprotective protocol including preoperative steroids, acetazolamide, intraoperative hemodynamic parameters, and postoperative treatment goals was initiated in November 2019. Physician-modified branched endovascular repairs were completed at a single center from 2012 to 2021 with outcomes reviewed both before (n = 107) and after (n = 67) the implementation of the neuroprotective protocol. The primary end point was the incidence of any SCI event at 30 days. Secondary end points included all-cause mortality, stroke, myocardial infarction, and renal failure at 30 days. Patients with Crawford extents I-III, renal failure, or necessitating emergent repair were deemed high risk for SCI events and underwent a subset analysis. Survivability after SCI was estimated using Kaplan-Meier tables. RESULTS: Of the 174 consecutive patients treated, the 67 patients treated following implementation of the neuroprotective protocol were more likely to have experienced a prior myocardial infarction (26.9% vs. 14%; P = 0.0466) and have a history of chronic obstructive pulmonary disease (64.3% vs. 45.8%; P = 0.02). This group was more likely to be treated for paravisceral aneurysms (53.7% vs. 24.3%; P = 0.0002). Postprotocol implementation, spinal drain use was lower (6% vs. 38.3%; P = <0.0001) with 100% of these drains placed in urgent or unstaged thoracoabdominal aortic aneurysm repairs as a part of the protocol. Rates of any SCI event among all patients before and after implementation of the protocol were 9.3% (n = 10 of 107) and 6% (n = 4 of 67; P = 0.57), respectively. In comparison, the protocol significantly reduced SCI rates to 0 (0% vs. 17.1%; P = 0.0407) in high-risk patients. Frequency of renal failure was reduced (3% vs. 14%; P = 0.018) after initiation of the protocol. Patients in the postprotocol group had significantly improved 1-year mortality rate (9% vs. 27.1%; P = 0.0035) and renal failure rates (2% vs. 15%; P = 0.018). Regression models indicated that patients in the postprotocol group had lower likelihood of mortality and renal failure than patients in preprotocol group (P < 0.05) and that spinal drain reduced mortality (P < 0.1). CONCLUSIONS: Implementation of a standardized neuroprotective protocol that focuses on medical management and fluid dynamics may significantly reduce risk of SCI after branched endovascular repairs, with the most significant improvement of SCI outcomes involving those at greatest risk for developing SCI. Also noteworthy, there was significant improvement to 1-year survivability after the implementation of this neuroprotective protocol.
引用
- Lucas SJ, Johnson KB, Rykhus R, et al. Single-Site Review of Spinal Cord Protection Protocols Including the Utilization of Spinal Drains versus Medical Management with Branched Endovascular Aortic Repair. Ann Vasc Surg. 2023. PMID: 37659649. doi:10.1016/j.avsg.2023.08.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。